IPO Reports >

IPO Review 2021, Mainboard IPO Analysis and Notes | Page 2

Mainline IPO Review by SEBI Registered Analysts provides in-depth IPO analysis to retail and HNI investors. This data-supported IPO forecast helps investors to decide if the IPO is worth investing. The reviews also provide IPO recommendations to tell you if IPO is good to buy and weather IPO good or bad.

The IPO views provide detail analysis of company background, offer detail, company valuation, capital structure, financial performance, strength, risks & benefits of investment, peer comparison and recommendation about IPO. These IPO note are presented to keep both short and long term investors in mind.

<< Year 2020	2021	Year 2022 > >

IPO Review 2021 | Page 2

#	Review Title	Author	Recommendation	IPO
201	Aditya Birla Sun Life AMC IPO Analysis by InvestorGain.com	InvestorGain.com	Apply	IPO
202	Paras Defence and Space Technologies IPO Analysis by Arihant Capital Markets Ltd	Arihant Capital Markets Ltd	Apply	IPO
203	Paras Defence and Space Technologies IPO Analysis by Arun Kejriwal	Arun Kejriwal	Apply	IPO
204	Paras Defence and Space Technologies IPO Analysis by Ashika Research	Ashika Research	Neutral	IPO
205	Paras Defence and Space Technologies IPO Analysis by Axis Capital	Axis Capital	Neutral	IPO
206	Paras Defence and Space Technologies IPO Analysis by Canara Bank	Canara Bank	Apply	IPO
207	Paras Defence and Space Technologies IPO Analysis by Capital Market	Capital Market	May apply	IPO
208	Paras Defence and Space Technologies IPO Analysis by Choice Equity Broking Pvt Ltd	Choice Equity Broking Pvt Ltd	Apply	IPO
209	Paras Defence IPO review	Dilip Davda	May apply	IPO
210	Paras Defence and Space Technologies IPO Analysis by Edelweiss Broking Ltd	Edelweiss Broking Ltd	Neutral	IPO
211	Paras Defence and Space Technologies IPO Analysis by Hem Securities	Hem Securities	Apply	IPO
212	Paras Defence and Space Technologies IPO Analysis by ICICI Direct	ICICI Direct	Neutral	IPO
213	Paras Defence and Space Technologies IPO Analysis by Investmentz Ltd	Investmentz Ltd	Apply	IPO
214	Paras Defence and Space Technologies IPO Analysis by JM Financial Institutional Securities	JM Financial Institutional Securities	Neutral	IPO
215	Paras Defence and Space Technologies IPO Analysis by Marwadi Shares and Finance Limited	Marwadi Shares and Finance Ltd	Apply	IPO
216	Paras Defence and Space Technologies IPO Analysis by Reliance Securities	Reliance Securities	Neutral	IPO
217	Paras Defence and Space Technologies IPO Analysis by Religare Broking Limited	Religare Broking Limited	Neutral	IPO
218	Paras Defence and Space Technologies IPO Analysis by StockEdge	StockEdge	Neutral	IPO
219	Paras Defence and Space Technologies IPO Analysis by InvestorGain.com	InvestorGain.com	Apply	IPO
220	Paras Defence and Space Technologies IPO Analysis by Ventura Securities Limited	Ventura Securities Limited	Apply	IPO
221	Sansera Engineering IPO Analysis by Axis Capital	Axis Capital	Neutral	IPO
222	Sansera Engineering IPO Analysis by BP Equities (BP Wealth)	BP Equities (BP Wealth)	Apply	IPO
223	Sansera Engineering IPO Analysis by Capital Market	Capital Market	Avoid	IPO
224	Sansera Engineering IPO Analysis by Choice Equity Broking Pvt Ltd	Choice Equity Broking Pvt Ltd	Apply	IPO
225	Sansera Engineering IPO review	Dilip Davda	Apply	IPO
226	Sansera Engineering IPO Analysis by ICICI Direct	ICICI Direct	Neutral	IPO
227	Sansera-Engineering IPO Analysis by JM Financial Institutional Securities	JM Financial Institutional Securities	Neutral	IPO
228	Sansera Engineering IPO Analysis by Kotak Securities	Kotak Securities	Neutral	IPO
229	Sansera Engineering IPO Analysis by Marwadi Shares and Finance Limited	Marwadi Shares and Finance Ltd	Apply	IPO
230	Sansera-Engineering-Ltd-IPO-Note-Religare-Broking	Religare Broking Limited	Neutral	IPO
231	Sansera Engineering IPO Analysis by SMC Global	SMC Global	Neutral	IPO
232	Ami Organics IPO Analysis by Anand Rathi	Anand Rathi	Apply	IPO
233	Ami Organics IPO Analysis by Axis Capital	Axis Capital	Neutral	IPO
234	Ami Organics IPO Analysis by Capital Market	Capital Market	May apply	IPO
235	Ami Organics IPO review	Dilip Davda	May apply	IPO
236	Ami Organics IPO Analysis by Investmentz Ltd	Investmentz Ltd	Apply	IPO
237	Ami Organics IPO Analysis by Kotak Securities	Kotak Securities	Neutral	IPO
238	Ami Organics IPO Analysis by Marwadi Shares and Finance Limited	Marwadi Shares and Finance Ltd	Apply	IPO
239	Ami Organics IPO Analysis by Motilal Oswal	Motilal Oswal	Apply	IPO
240	Ami Organics IPO Analysis by StockEdge	StockEdge	Neutral	IPO
241	Ami Organics IPO Analysis by InvestorGain.com	InvestorGain.com	Apply	IPO
242	Vijaya Diagnostic IPO Analysis by Arihant Capital Markets Ltd	Arihant Capital Markets Ltd	Apply	IPO
243	Vijaya Diagnostic IPO Analysis by Axis Capital	Axis Capital	Neutral	IPO
244	Vijaya Diagnostic IPO Analysis by Capital Market	Capital Market	Avoid	IPO
245	Vijaya Diagnostic IPO review	Dilip Davda	May apply	IPO
246	Vijaya Diagnostic IPO Analysis by HDFC Securities Limited	HDFC Securities Limited	Neutral	IPO
247	Vijaya Diagnostic IPO Analysis by Hem Securities	Hem Securities	Apply	IPO
248	Vijaya Diagnostic IPO Analysis by IIFL Securities	IIFL Securities	Apply	IPO
249	Vijaya Diagnostic IPO Analysis by JM Financial Institutional Securities	JM Financial Institutional Securities	Neutral	IPO
250	Vijaya Diagnostic IPO Analysis by Kotak Securities	Kotak Securities	Neutral	IPO
251	Vijaya Diagnostic IPO Analysis by KR Choksey Securities Ltd	KR Choksey Securities Ltd	Apply	IPO
252	Vijaya Diagnostic IPO Analysis by Marwadi Shares and Finance Limited	Marwadi Shares and Finance Ltd	Apply	IPO
253	Vijaya Diagnostic IPO Analysis by Mehta Equities	Mehta Equities	Apply	IPO
254	Vijaya Diagnostic IPO Analysis by Reliance Securities	Reliance Securities	Apply	IPO
255	Vijaya Diagnostic IPO Analysis by Religare Broking Limited	Religare Broking Limited	Neutral	IPO
256	Vijaya Diagnostic IPO Analysis by InvestorGain.com	InvestorGain.com	Avoid	IPO
257	Vijaya Diagnostic IPO Analysis by Ventura Securities Limited	Ventura Securities Limited	Apply	IPO
258	Chemplast Sanmar IPO Analysis by Axis Capital	Axis Capital	Neutral	IPO
259	Chemplast Sanmar IPO Analysis by Capital Market	Capital Market	Avoid	IPO
260	Chemplast Sanmar IPO review	Dilip Davda	May apply	IPO
261	Chemplast Sanmar IPO Analysis by Edelweiss Broking Ltd	Edelweiss Broking Ltd	Neutral	IPO
262	Chemplast Sanmar IPO Analysis by InvestorGain.com	InvestorGain.com	Avoid	IPO
263	Aptus Value Housing Finance IPO Analysis by Arun Kejriwal	Arun Kejriwal	Avoid	IPO
264	Aptus Value Housing Finance IPO Analysis by Ashika Research	Ashika Research	Apply	IPO
265	Aptus Value Housing Finance IPO Analysis by Axis Capital	Axis Capital	Neutral	IPO
266	Aptus Value Housing Finance IPO Analysis by Capital Market	Capital Market	May apply	IPO
267	Aptus Value Housing Finance IPO Analysis by Choice Equity Broking Pvt Ltd	Choice Equity Broking Pvt Ltd	May apply	IPO
268	Aptus Value IPO review	Dilip Davda	May apply	IPO
269	Aptus Value Housing Finance IPO Analysis by Edelweiss Broking Ltd	Edelweiss Broking Ltd	Neutral	IPO
270	Aptus Value Housing Finance IPO Analysis by HDFC Securities Limited	HDFC Securities Limited	Neutral	IPO
271	Aptus Value Housing Finance IPO Analysis by Hem Securities	Hem Securities	Apply	IPO
272	Aptus Value Housing Finance IPO Analysis by ICICI Direct	ICICI Direct	Neutral	IPO
273	Aptus Value Housing Finance IPO Analysis by Religare Broking Limited	Religare Broking Limited	Neutral	IPO
274	Aptus Value Housing Finance IPO Analysis by Ventura Securities Limited	Ventura Securities Limited	Neutral	IPO
275	CarTrade Tech IPO Analysis by Anand Rathi	Anand Rathi	Apply	IPO
276	CarTrade Tech IPO Analysis by Arun Kejriwal	Arun Kejriwal	Apply	IPO
277	CarTrade Tech IPO Analysis by Ashika Research	Ashika Research	Apply	IPO
278	CarTrade Tech IPO Analysis by Axis Capital	Axis Capital	Neutral	IPO
279	CarTrade Tech IPO Analysis by BP Equities (BP Wealth)	BP Equities (BP Wealth)	Apply	IPO
280	CarTrade Tech IPO Analysis by Canara Bank	Canara Bank	Avoid	IPO
281	CarTrade Tech IPO Analysis by Capital Market	Capital Market	May apply	IPO
282	CarTrade Tech IPO review	Dilip Davda	May apply	IPO
283	CarTrade Tech IPO Analysis by Edelweiss Broking Ltd	Edelweiss Broking Ltd	Neutral	IPO
284	CarTrade Tech IPO Analysis by HDFC Securities Limited	HDFC Securities Limited	Neutral	IPO
285	CarTrade Tech IPO Analysis by Hem Securities	Hem Securities	Apply	IPO
286	CarTrade Tech IPO Analysis by ICICI Direct	ICICI Direct	Apply	IPO
287	CarTrade Tech IPO Analysis by Investmentz Ltd	Investmentz Ltd	Apply	IPO
288	CarTrade Tech IPO Analysis by JM Financial Institutional Securities	JM Financial Institutional Securities	Neutral	IPO
289	CarTrade Tech IPO Analysis by Motilal Oswal	Motilal Oswal	Apply	IPO
290	CarTrade Tech IPO Analysis by Nirmal Bang	Nirmal Bang	Apply	IPO
291	CarTrade Tech IPO Analysis by InvestorGain.com	InvestorGain.com	Apply	IPO
292	CarTrade Tech IPO Analysis by Ventura Securities Limited	Ventura Securities Limited	Neutral	IPO
293	Nuvoco IPO Analysis by Angel One	Angel One	Apply	IPO
294	Nuvoco IPO Analysis by Arun Kejriwal	Arun Kejriwal	May apply	IPO
295	Nuvoco IPO Analysis by Axis Capital	Axis Capital	Neutral	IPO
296	Nuvoco IPO Analysis by Canara Bank	Canara Bank	Apply	IPO
297	Nuvoco IPO Analysis by Capital Market	Capital Market	Avoid	IPO
298	Nuvoco Vistas IPO review	Dilip Davda	May apply	IPO
299	Nuvoco IPO Analysis by Edelweiss Broking Ltd	Edelweiss Broking Ltd	Neutral	IPO
300	Nuvoco IPO Analysis by HDFC Securities Limited	HDFC Securities Limited	Neutral	IPO
301	Nuvoco IPO Analysis by Hem Securities	Hem Securities	Apply	IPO
302	Nuvoco IPO Analysis by ICICI Direct	ICICI Direct	Neutral	IPO
303	Nuvoco IPO Analysis by IDBI Capital	IDBI Capital	Apply	IPO
304	Nuvoco IPO Analysis by Investmentz Ltd	Investmentz Ltd	Apply	IPO
305	Nuvoco IPO Analysis by KR Choksey Securities Ltd	KR Choksey Securities Ltd	Apply	IPO
306	Nuvoco IPO Analysis by InvestorGain.com	InvestorGain.com	Avoid	IPO
307	Krsnaa Diagnostics IPO Analysis by Axis Capital	Axis Capital	Neutral	IPO
308	Krsnaa Diagnostics IPO Analysis by Capital Market	Capital Market	Avoid	IPO
309	Krsnaa Diagno IPO review	Dilip Davda	May apply	IPO
310	Krsnaa Diagnostics IPO Analysis by Hem Securities	Hem Securities	Apply	IPO
311	Krsnaa Diagnostics IPO Analysis by JM Financial Institutional Securities	JM Financial Institutional Securities	Neutral	IPO
312	Krsnaa Diagnostics IPO Analysis by KR Choksey Securities Ltd	KR Choksey Securities Ltd	Apply	IPO
313	Krsnaa Diagnostics IPO Analysis by InvestorGain.com	InvestorGain.com	Apply	IPO
314	Devyani International IPO Analysis by Angel One	Angel One	Apply	IPO
315	Devyani International IPO Analysis by Arun Kejriwal	Arun Kejriwal	Apply	IPO
316	Devyani International IPO Analysis by Ashika Research	Ashika Research	Apply	IPO
317	Devyani International IPO Analysis by Axis Capital	Axis Capital	Neutral	IPO
318	Devyani International IPO Analysis by BP Equities (BP Wealth)	BP Equities (BP Wealth)	Apply	IPO
319	Devyani International IPO Analysis by Canara Bank	Canara Bank	Apply	IPO
320	Devyani International IPO Analysis by Capital Market	Capital Market	May apply	IPO
321	Devyani International IPO Analysis by Choice Equity Broking Pvt Ltd	Choice Equity Broking Pvt Ltd	Apply	IPO
322	Devyani Intl IPO review	Dilip Davda	May apply	IPO
323	Devyani International IPO Analysis by ICICI Direct	ICICI Direct	Apply	IPO
324	Devyani International IPO Analysis by Investmentz Ltd	Investmentz Ltd	Apply	IPO
325	Devyani International IPO Analysis by JM Financial Institutional Securities	JM Financial Institutional Securities	Neutral	IPO
326	Devyani International IPO Analysis by Nirmal Bang	Nirmal Bang	Apply	IPO
327	Devyani International IPO Analysis by Prabhudas Lilladher Pvt Ltd	Prabhudas Lilladher Pvt Ltd	Apply	IPO
328	Devyani International IPO Analysis by Religare Broking Limited	Religare Broking Limited	Neutral	IPO
329	Devyani International IPO Analysis by Sharekhan Limited	Sharekhan Limited	Neutral	IPO
330	Windlas Biotech IPO Analysis by Capital Market	Capital Market	Avoid	IPO
331	Windlas Bio IPO review	Dilip Davda	May apply	IPO
332	Windlas Biotech IPO Analysis by JM Financial Institutional Securities	JM Financial Institutional Securities	Neutral	IPO
333	Windlas Biotech IPO Analysis by InvestorGain.com	InvestorGain.com	Apply	IPO
334	Exxaro Tiles IPO Analysis by Arihant Capital Markets Ltd	Arihant Capital Markets Ltd	Apply	IPO
335	Exxaro Tiles IPO Analysis by Arun Kejriwal	Arun Kejriwal	May apply	IPO
336	Exxaro Tiles IPO Analysis by AUM Capital Ltd	AUM Capital Ltd	Neutral	IPO
337	Exxaro Tiles IPO Analysis by Canara Bank	Canara Bank	Apply	IPO
338	Exxaro Tiles IPO Analysis by Capital Market	Capital Market	May apply	IPO
339	Exxaro Tiles IPO review	Dilip Davda	May apply	IPO
340	Exxaro Tiles IPO Analysis by Hem Securities	Hem Securities	Apply	IPO
341	Exxaro Tiles IPO Analysis by JM Financial Institutional Securities	JM Financial Institutional Securities	Neutral	IPO
342	Exxaro Tiles IPO Analysis by Reliance Securities	Reliance Securities	Neutral	IPO
343	Exxaro Tiles IPO Analysis by SMC Global	SMC Global	Apply	IPO
344	Rolex Rings IPO Analysis by Axis Capital	Axis Capital	Neutral	IPO
345	Rolex Rings IPO Analysis by Capital Market	Capital Market	May apply	IPO
346	Rolex Rings IPO review	Dilip Davda	Apply	IPO
347	Rolex Rings IPO Analysis by Hem Securities	Hem Securities	Apply	IPO
348	Rolex Rings IPO Analysis by ICICI Direct	ICICI Direct	Apply	IPO
349	Rolex Rings IPO Analysis by KR Choksey Securities Ltd	KR Choksey Securities Ltd	Apply	IPO
350	Rolex Rings IPO Analysis by Reliance Securities	Reliance Securities	Apply	IPO
351	Rolex Rings IPO Analysis by Ventura Securities Limited	Ventura Securities Limited	Apply	IPO
352	Glenmark Life Sciences IPO Analysis by Anand Rathi	Anand Rathi	Apply	IPO
353	Glenmark Life Sciences IPO Analysis by Ashika Research	Ashika Research	Apply	IPO
354	Glenmark Life Sciences IPO Analysis by Axis Capital	Axis Capital	Neutral	IPO
355	Glenmark Life Sciences IPO Analysis by Capital Market	Capital Market	May apply	IPO
356	Glenmark Life Sciences IPO Analysis by Choice Equity Broking Pvt Ltd	Choice Equity Broking Pvt Ltd	Apply	IPO
357	Glenmark Life IPO review	Dilip Davda	May apply	IPO
358	Glenmark Life Sciences IPO Analysis by Dolat Analysis and Research	Dolat Analysis and Research	Apply	IPO
359	Glenmark Life Sciences IPO Analysis by GEPL Capital Ltd	GEPL Capital Ltd	Apply	IPO
360	Glenmark Life Sciences IPO Analysis by HDFC Securities Limited	HDFC Securities Limited	Neutral	IPO
361	Glenmark Life Sciences IPO Analysis by ICICI Direct	ICICI Direct	Apply	IPO
362	Glenmark Life Sciences IPO Analysis by Investmentz Ltd	Investmentz Ltd	Apply	IPO
363	Glenmark Life Sciences IPO Analysis by SMC Global	SMC Global	May apply	IPO
364	Glenmark Life Sciences IPO Analysis by Sushil Finance Ltd	Sushil Finance Ltd	Apply	IPO
365	Glenmark Life Sciences IPO Analysis by InvestorGain.com	InvestorGain.com	Apply	IPO
366	Glenmark Life Sciences IPO Analysis by Ventura Securities Limited	Ventura Securities Limited	Apply	IPO
367	Tatva Chintan Pharma IPO Analysis by Axis Capital	Axis Capital	Neutral	IPO
368	Tatva Chintan Pharma IPO Analysis by Capital Market	Capital Market	May apply	IPO
369	Tatva Chintan IPO review	Dilip Davda	Apply	IPO
370	Tatva Chintan Pharma IPO Analysis by Investmentz Ltd	Investmentz Ltd	Apply	IPO
371	Tatva Chintan Pharma IPO Analysis by KR Choksey Securities Ltd	KR Choksey Securities Ltd	Apply	IPO
372	Tatva Chintan Pharma IPO Analysis by Motilal Oswal	Motilal Oswal	Apply	IPO
373	Tatva Chintan Pharma IPO Analysis by Reliance Securities	Reliance Securities	Apply	IPO
374	Tatva Chintan Pharma IPO Analysis by Sharekhan Limited	Sharekhan Limited	Neutral	IPO
375	Tatva Chintan Pharma IPO Analysis by InvestorGain.com	InvestorGain.com	Apply	IPO
376	Tatva Chintan Pharma IPO Analysis by Ventura Securities Limited	Ventura Securities Limited	Apply	IPO
377	Zomato IPO Analysis by Ambit Capital Pvt Ltd	Ambit Capital Pvt Ltd	Neutral	IPO
378	Zomato IPO Analysis by Axis Capital	Axis Capital	Neutral	IPO
379	Zomato IPO Analysis by Capital Market	Capital Market	May apply	IPO
380	Zomato IPO Analysis by Choice Equity Broking Pvt Ltd	Choice Equity Broking Pvt Ltd	May apply	IPO
381	Zomato IPO review	Dilip Davda	Avoid	IPO
382	Zomato IPO Analysis by GEPL Capital Ltd	GEPL Capital Ltd	Apply	IPO
383	Zomato IPO Analysis by ICICI Securities	ICICI Securities	Neutral	IPO
384	Zomato IPO Analysis by KR Choksey Securities Ltd	KR Choksey Securities Ltd	Apply	IPO
385	Zomato IPO Analysis by Religare Broking Limited	Religare Broking Limited	Neutral	IPO
386	Zomato IPO Analysis by Sharekhan Limited	Sharekhan Limited	Neutral	IPO
387	Zomato IPO Analysis by Ventura Securities Limited	Ventura Securities Limited	Apply	IPO
388	Clean Science IPO Analysis by Aditya Birla Ltd	Aditya Birla Ltd	Apply	IPO
389	Clean Science IPO Analysis by Angel One	Angel One	Apply	IPO
390	Clean Science IPO Analysis by Ashika Research	Ashika Research	Apply	IPO
391	Clean Science IPO Analysis by Axis Capital	Axis Capital	Not Rated	IPO
392	Clean Science IPO Analysis by BP Equities (BP Wealth)	BP Equities (BP Wealth)	Apply	IPO
393	Clean Science IPO Analysis by Canara Bank	Canara Bank	Apply	IPO
394	Clean Science IPO Analysis by Capital Market	Capital Market	Apply	IPO
395	Clean Science IPO review	Dilip Davda	May apply	IPO
396	Clean Science IPO Analysis by GEPL Capital Ltd	GEPL Capital Ltd	Apply	IPO
397	Clean Science IPO Analysis by HDFC Securities Limited	HDFC Securities Limited	Neutral	IPO
398	Clean Science IPO Analysis by Hem Securities	Hem Securities	Apply	IPO
399	Clean Science IPO Analysis by ICICI Direct	ICICI Direct	Apply	IPO
400	Clean Science IPO Analysis by IIFL Securities	IIFL Securities	Apply	IPO
First Prev 2 of 4 Next Last

		Compare

Compare

<< Year 2020	2021	Year 2022 > >

More IPO reports ...List of all reports